Memory pill maker sued on grounds no proof it works

By Diane Bartz WASHINGTON (Reuters) – Quincy Bioscience LLC, which makes the memory supplement Prevagen, was hit with a lawsuit on Monday filed by the Federal Trade Commission and New York attorney general’s office, which alleged that there is no proof the supplement works. The lawsuit, which was filed in the U.S. District Court for the Southern District of New York, said that Quincy Bioscience had sold some $165 million worth of Prevagen between 2007 and mid-2015, according to court filings. The lawsuit says that Quincy Bioscience based much of its advertising for Prevagen on a single study, called the Madison Memory Study, which gave the drug or a placebo to 218 people and then had them perform certain tasks on a computer.
Source: Feed3

Leave a Reply

Your email address will not be published. Required fields are marked *